Strategic Partnerships Radiopharmacy has engaged in multiple high-profile collaborations and recent acquisitions within the radiopharmaceutical CDMO space, signaling openness to strategic partnerships that expand capabilities and market reach. Leverage this to propose joint ventures, co-development deals, or supplier collaborations to scale production and access new isotopes or therapies.

Leadership Transition Recent CFO departure and a new CEO appointment at PharmaLogic indicate active leadership changes and potential strategic pivots. This creates an opportunity to engage through tailored value propositions addressing financial discipline, scalable operations, and accelerated go-to-market plans aligned with the new leadership.

Expansion Footprint Radiopharmacy has announced facility expansions in Los Angeles and Salt Lake City, signaling growth and increased production capacity. This suggests a need for expanded supply chain support, ERP scalability, and logistics optimization services to ensure reliable distribution of radiopharmaceuticals.

Growth Financing Warmth With revenue in the 10-25 million range and ongoing expansions, Radiopharmacy may seek funding for further capacity, equipment, or acquisitions. Target conversations around financing advisory, capital equipment procurement, and ERP or EPM investments (NetSuite, SAP) to support scale.

Technology Stack Synergies Existing tech stack includes SAP, NetSuite, DocuSign, Smartsheet and more, indicating mature workflow and data capabilities. Propose integrated solutions, process automation, data analytics, and compliance tooling to improve production efficiency, regulatory readiness, and supplier management.